EGF anticorps (C-Term) (FITC)
Aperçu rapide pour EGF anticorps (C-Term) (FITC) (ABIN2257852)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 939-967, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- EGF, CT (EGF, Pro-epidermal growth factor, Epidermal growth factor, Urogastrone) (FITC)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- EGF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 939-967 amino acids from the C-terminal region of human EGF.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- EGF
-
NCBI Accession
- NP_001954
-
UniProt
- P01133
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-